|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,72,600.00 KRW | -1.82% |
|
-1.43% | +0.13% |
| 14/07 | Celltrion Terminates, Withdraws EMA Trial Application for CT-P51 Biosimilar | MT |
| 07/07 | Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Neutral |
| Resistance | 1,83,600 | 1,89,238 | 2,30,476 |
| Spread/Res. | -5.99% | -8.79% | -25.11% |
| Spread/Supp. | +1.02% | +8.28% | +8.13% |
| Support | 1,70,857 | 1,59,400 | 1,59,619 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- A068270 Stock
- Charts Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition